GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kodiak Sciences Inc (FRA:K27) » Definitions » Future Policy Benefits

Kodiak Sciences (FRA:K27) Future Policy Benefits


View and export this data going back to 2020. Start your Free Trial

What is Kodiak Sciences Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Kodiak Sciences (FRA:K27) Business Description

Traded in Other Exchanges
Address
1200 Page Mill Road, Palo Alto, CA, USA, 94304
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.